| 发明名称 |
BISPECIFIC DOMAIN ANT1BODIES TARGETING SERUM ALBUMIN AND GLP-1 OR PYY |
| 摘要 |
Drug fusions and conjugates that contain an incretin therapeutic or diagnostic agent that is fused or conjugated to an antigen-binding fragment of an antibody that binds serum albumin. The conjugates and fusion have a longer in vivo half life in comparison with the unconjugated or unfused therapeutic or diagnostic agent.
|
| 申请公布号 |
KR20070094909(A) |
申请公布日期 |
2007.09.27 |
| 申请号 |
KR20077015211 |
申请日期 |
2007.07.02 |
| 申请人 |
DOMANTIS LIMITED |
发明人 |
HOLMES STEVE;HOLT LUCY J.;JESPERS LAURENT S.;TOMLINSON IAN M. |
| 分类号 |
A61K47/48;A61P1/00;A61P3/10;C07K16/44 |
主分类号 |
A61K47/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
